Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07NLI
|
|||
| Former ID |
DIB011130
|
|||
| Drug Name |
Vismed
|
|||
| Indication | Eye disorder [ICD-11: 9A01-9A0Z; ICD-10: H00-H59] | Phase 4 | [1], [2] | |
| Company |
Lantibio
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02117687) A Safety and Efficacy Study of OPTIVE FUSION With VISMED Multi for the Management of Dry Eye. U.S. National Institutes of Health. | |||
| REF 2 | Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease. Eur J Ophthalmol. 2012 Sep-Oct;22(5):751-61. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.